|
Market Closed -
Australian S.E.
07:51:07 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1100 AUD | 0.00% |
|
-8.33% | -26.67% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 56.46 | - | - |
| Change | - | - | 343.99% | -53.17% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 38.56 | 33.06 | 39.06 |
| Change | - | - | 241.42% | -58.41% | -14.26% | 18.15% |
| P/E | -2.64x | -3.27x | -14.3x | -4.78x | -15.7x | -10x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.2x | -0.2x |
| Capitalization / Revenue | - | - | - | - | 5.94x | 5.94x |
| EV / Revenue | - | - | - | - | 3.48x | 4.11x |
| EV / EBITDA | - | - | -11.2x | -3.35x | -8.27x | -6.51x |
| EV / EBIT | - | - | -11.1x | -3.32x | -8.06x | -6.4x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1100 | 0.1100 | 0.1100 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 5/30/23 A | 5/30/25 A | 5/29/26 A | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.78x | - | -3.35x | - | 39.24M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 18.40x | 31.37x | 10.89x | 0.31% | 39.06B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
